Featured Portfolio
NeckR introduces an approach to aneurysm treatment with three distinct solutions in one elegantly designed device. Its unique positioning system and targeted flow diversion effect aim to revolutionize the treatment landscape for brain aneurysms.
TOP STORIES
PATENTS AND TECHNOLOGY
Newellis Secures New Patent For Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™
by Nuwellis in June ‘24
Nuwellis is currently developing Vivian, a new, fully integrated pediatric continuous renal replacement therapy (CRRT) device designed to provide care for small babies and children with limited or no kidney function. Vivian is not yet cleared by the FDA. This development effort was funded in part by a $1.7 million grant from the National Institutes of Health (NIH). |
Novo Nordisk's Wegovy weight-loss drug approved in China
by Reuters in June ‘24
Novo Nordisk’s (NOVOb.CO), opens new tab hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world’s second-largest economy and the country estimated to hold the highest number of overweight or obese people. |
Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia
by Globe Newswire in June ‘24
Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No 12,011,591 relating to the Company’s non-invasive Deep Intracranial Frequency Stimulation (DIFS®) medical device for the treatment of Alzheimer’s and other dementia-related brain diseases. |
TOP STORIES
HEALTHCARE TRANSACTIONS
US appeals court revives Amarin heart-drug patent lawsuit over Hikma generic
by Reuters in June ‘24
Amarin Pharma convinced a U.S. appeals court on Tuesday to resurrect a patent infringement lawsuit over Hikma Pharmaceuticals’ generic version of Amarin’s cardiovascular drug Vascepa. |
Boston Scientific spends $1.26bn to acquire TCAR specialist Silk Road Medical
by Medical Device Network in June ‘24
Boston Scientific has agreed to acquire Silk Road Medical for around $1.26bn, adding the US-based carotid artery device specialist to its roster.
RECENTLY
ISSUED PATENTS
Avicanna Announces USPTO Issuance of Patent SEDDS Technology
by KXAN News in June ‘24
Patent No. US 11,998,632 B2 (“Patent”) covers Avicanna’s self-emulsifying drug delivery system (“SEDDS”) oral cannabinoid composition and methods of treating neuropathic pain.
BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach
by DiCardiology in June ‘24
BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced that the Unites States Patent Office has granted Patent No: 11,986,611 titled “Radial and Transendocardial Delivery Catheter,” with a patent term that will expire in 2036. |
CURRENT PORTFOLIO AVAILABLE
FOR SALE
AND LICENSE WITH HIGH INTEREST
Traditional ventral hernia surgical meshes often lead to severe complications. XyberCyl offers a breakthrough solution with its complication-free repair. Its monofilament silicone and patented wide-open spaces prevent irritation and foreign body reactions, fostering an environment for natural healing and ensuring a permanent repair. XyberCyl creates and maintains optimal conditions for the body to heal itself. |
